Wnn lastly the state of Hesse and Rhön-Klinikum AG agree on a new future contract for the University Hospital Gießen and Marburg? In mid-January, either side introduced the cornerstones of their declaration of intent. In accordance with this, the state desires to pump virtually half a billion euros into the bigger of the 2 Hessian university clinics over a interval of ten years. Though Prime Minister Volker Bouffier (CDU) praised the fundamental settlement and representatives of the bulk proprietor Rhön-Klinikum had been relieved, there are issues within the talks concerning the subtleties. Rhön-Klinikum AG even expresses doubts about an early conclusion and threatens to terminate the earlier settlement, barely hid. Science Minister Angela Dorn (The Greens) reacts coolly. Unity appears to be like totally different. And that is unhealthy.
As a result of what remains to be the one privatized university hospital in Germany wants state cash, and it does so urgently. Much like earlier than the privatization in February 2006, the chief flooring of the clinic right this moment complains about an funding backlog within the tons of of thousands and thousands. The Giessen location particularly is in a a lot better place than it was then. In the end, nonetheless, the university hospital pays for the brand new central constructing and the youngsters’s clinic itself.
Rhön loans usually are not a resolution
As a result of the investments are based mostly on loans from Rhön AG, which holds 95 p.c of the corporate. The state, as a minority shareholder, has thus far solely paid a good eight million euros a 12 months for building tasks and tools for each places. As a end result, the clinic has to generate virtually 40 million euros in repayments and curiosity per 12 months. Though, in distinction to virtually all different university hospitals on this nation, it nonetheless makes a revenue, trimmed tightly for effectivity, this isn’t a mannequin for the long run. Rhön AG and Land know that. It’s unacceptable that a firm dedicated to cutting-edge medication has to wrestle to purchase new tools.
Nonetheless, each shareholders have gotten caught in a basic dispute over the query of whether or not the state, as within the case of the Frankfurt University Hospital, should additionally pay for investments along with personnel prices. There’s definitely a authorized dispute about this. This doesn’t assist the bigger of the 2 Hessian university clinics, the staff and sufferers. Nevertheless it’s about her.